EUVIMEDEUVIMED entdecken
Open Access

RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine

Vasiliki Mitsi, Anne Ruiz, Claire Polizu, Zahra Farzinpour, Aarthi Ramakrishnan, Randal A Serafini iD, Eric M Parise, Madeline Floodstrand iD, Omar K Sial, Sevasti Gaspari, Cheuk Y Tang, Eric J Nestler und 3 weitere

Molecular Pharmacology · 2024

DOI: 10.1124/molpharm.123.000753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmacology, 2024. Verfasst von Vasiliki Mitsi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nash Family Department of Neuroscience and Friedman Brain Institute (V.M., A.Ru., C.P., A.Ra., R.A.S., E.M.P. M.F., S.G., E.J.N., L.S.) and BioMedica…. Hauptthemen laut MEDLINE: Ketamine, Major Depressive Disorder, RGS Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The signal transduction protein, regulator of G protein signaling 4 (RGS4), plays a prominent role in physiologic and pharmacological responses by controlling multiple intracellular pathways. Our earlier work identified the dynamic but distinct roles of RGS4 in the efficacy of monoamine-targeting versus fast-acting antidepressants. Using a modified chronic variable stress (CVS) paradigm in mice, we demonstrate that stress-induced behavioral abnormalities are associated with the downregulation of RGS4 in the medial prefrontal cortex (mPFC). Knockout of RGS4 (RGS4KO) increases susceptibility to CVS, as mutant mice develop behavioral abnormalities as early as 2 weeks after CVS resting-state functional magnetic resonance imaging I (rs-fMRI) experiments indicate that stress susceptibility in RGS4KO mice is associated with changes in connectivity between the mediodorsal thalamus (MD-THL) and the mPFC. Notably, RGS4KO also paradoxically enhances the antidepressant efficacy of ketamine in the CVS paradigm. RNA-sequencing analysis of naive and CVS samples obtained from mPFC reveals that RGS4KO triggers unique gene expression signatures and affects several intracellular pathways associated with human major depressive disorder. Our analysis suggests that ketamine treatment in the RGS4KO group triggers changes in pathways implicated in synaptic activity and responses to stress, including pathways associated with axonal guidance and myelination. Overall, we show that reducing RGS4 activity triggers unique gene expression adaptations that contribute to chronic stress disorders and that RGS4 is a negative modulator of ketamine actions. SIGNIFICANCE STATEMENT: Chronic stress promotes robust maladaptation in the brain, but the exact intracellular pathways contributing to stress vulnerability and mood disorders have not been thoroughly investigated. In this study, the authors used murine models of chronic stress and multiple methodologies to demonstrate the critical role of the signal transduction modulator regulator of G protein signaling 4 in the medial prefrontal cortex in vulnerability to chronic stress and the efficacy of the fast-acting antidepressant ketamine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineMajor Depressive DisorderRGS ProteinsMiceHumansAnimalsTranscriptomeMice, KnockoutAntidepressive AgentsPrefrontal CortexGene Expression ProfilingGTP-Binding Proteins

Substanzen

KetamineRGS ProteinsAntidepressive AgentsGTP-Binding Proteins

Autor:innen und Institutionen

  • Nash Family Department of Neuroscience and Friedman Brain Institute (V.M., A.Ru., C.P., A.Ra., R.A.S., E.M.P. M.F., S.G., E.J.N., L.S.) and BioMedical Engineering and Imaging Institute (C.Y.T.), Icahn School of Medicine…

ORCID-Profile: Randal A Serafini, Madeline Floodstrand

Förderung

  • NIMH NIH HHS
  • NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Mitsi, V., Ruiz, A., Polizu, C., Farzinpour, Z., Ramakrishnan, A., Serafini, R. A., Parise, E. M., Floodstrand, M., Sial, O. K., Gaspari, S., Tang, C. Y., Nestler, E. J., Schmidt, E. F., Shen, L., & Zachariou, V. (2024). RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine. Molecular Pharmacology. https://doi.org/10.1124/molpharm.123.000753

Vancouver

Mitsi V, Ruiz A, Polizu C, Farzinpour Z, Ramakrishnan A, Serafini RA, et al. RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine. Molecular Pharmacology. 2024. doi:10.1124/molpharm.123.000753

BibTeX
@article{Mitsi2024,
  author = {Mitsi, Vasiliki and Ruiz, Anne and Polizu, Claire and Farzinpour, Zahra and Ramakrishnan, Aarthi and Serafini, Randal A and Parise, Eric M and Floodstrand, Madeline and Sial, Omar K and Gaspari, Sevasti and Tang, Cheuk Y and Nestler, Eric J and Schmidt, Eric F and Shen, Li and Zachariou, Venetia},
  title = {RGS4 Actions in Mouse Prefrontal Cortex Modulate Behavioral and Transcriptomic Responses to Chronic Stress and Ketamine},
  journal = {Molecular Pharmacology},
  year = {2024},
  doi = {10.1124/molpharm.123.000753}
}
Kostenlos starten →